Frequency of Chlamydia trachomatis in a population of pregnant women from a public hospital in Northern Argentina
DOI:
https://doi.org/10.18004/mem.iics/1812-9528/2024.e22122406Keywords:
Chlamydia, pregnant women, PCRAbstract
Chlamydia trachomatis (CT) is a microorganism that causes the most prevalent bacterial sexually transmitted infection in the world. During pregnancy it can cause abortion, prematurity and low birth weight. The most common perinatal clinical manifestations are inclusion conjunctivitis and respiratory tract infection. CT infection in pregnant women has been reported in different countries and in Argentina few studies were carried out and its detection is not included in control programs. The Argentine Northwest is no stranger to the lack of data related to this infection, which is why this study includes a total of 250 pregnant women who attended the “Dr. Héctor Quintana” from San Salvador de Jujuy, for pregnancy control. Several swabs were taken to detect CT by polymerase chain reaction and perform vaginal exudate. The frequency of CT was 7.6%, in concordance with global and Argentinean cases. All the analyzed variables were found to constitute risk factors, more frequently in women under 25 years of age, which is explained by the anatomical characteristic that favors infection. A total of 22.64% of symptomatic patients had CT infection and a significant association between CT and abortion or premature birth was demonstrated. Furthermore, a greater frequency was observed in basic vaginal stages II and V. In conclusion, this study provided the first local epidemiological data in a particularly vulnerable population for this infection, considering that Argentina does not have a consensus for chlamydia screening during pregnancy.
Downloads
References
1. World Health Organization, Dept. of Reproductive Health and Research. Estrategia mundial del sector de la salud contra las infecciones de transmisión sexual, 2016-2021. 2016. https://www.paho.org/es/documentos/estrategia-mundial-sector-salud-contra-infecciones-transmision-sexual-2016-2021-hacia
2. Murray, Sam & McKay, Paul. Chlamydia trachomatis: Cell biology, immunology and vaccination. Vaccine. 2021; 39. 10.1016/j.vaccine.2021.03.043.
3. Tjahyadi D, Ropii B, Tjandraprawira KD, Parwati I, Djuwantono T, Permadi W, Li T. Female urogenital chlamydia: Epidemiology, chlamydia on pregnancy, current diagnosis, and treatment. Ann Med Surg (Lond). 2022 Mar 2;75: 103448. 10.1016/j.amsu.2022.103448. PMID: 35386801; PMCID: PMC8977933.
3. Tang W, Mao J, Li KT, Walker JS, Chou R, Fu R, et al. Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis. Sex Transm Infect. 2020 Aug; 96 (5): 322-329. 10.1136/sextrans-2019-053999. Epub 2019 Dec 13. PMID: 31836678; PMCID: PMC7292777.
4. Honkila M, Renko M, Pokka T, et al. Symptoms, signs and long-term prognosis of vertically transmitted Chlamydia trachomatis infections. Pediatr Infect Dis J. 2018; 37:930-933.
5. Simons JL, McKenzie JS, Wright NC, et al. Chlamydia Prevalence by Age and Correlates of Infection Among Pregnant Women. Sex Transm Dis. 2021; 48(1): 37-41. 10.1097/OLQ.0000000000001261
6. Public Health Agency of Canada. Report on sexually transmitted infections in Canada. Ottawa: Government of Canada; 2019. Available at: Available at: https://www.canada.ca/en/public-health/services/publications/diseasesconditions/report-sexually-transmitted-infections-canada-2017.html . Accessed on 17 July 2020
7. Stevens-Simon C, Sheeer J. Chlamydia trachomatis: common misperceptions and misunderstandings. J Pediatr Adolesc Gynecol 2005; 18: 231-43.
8. Fleming N, O’Driscoll T, Becker G, et al. Adolescent pregnancy guidelines. J Obstet Gynaecol Can 2015; 37: 740-56.
9. Galvão JJDS, Cunha CLF, Pinho E CC, Paiva D JDS, de Castro NJ C, Nascimento V GC, et al. Seroprevalence of Chlamydia trachomatis and Associated Factors among Vulnerable Riverine in the Brazilian Amazon. International journal of environmental research and public health, 2022; 19(23): 15969. https://doi.org/10.3390/ijerph192315969
10. Simons JL, McKenzie JS, Wright NC, Sheikh SA, Subramaniam A, Tita ATN, Dionne-Odom J. Chlamydia Prevalence by Age and Correlates of Infection Among Pregnant Women. Sex Transm Dis. 2021 Jan;48(1):37-41. 10.1097/OLQ.000000000000126. PMID: 32932385; PMCID: PMC7737858.
11. Head MG, Fitchett JR, Cassell JA, Atun R. Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions. J. Glob. Health. 2015; 5(2): 1-9.
12. Nyemba DC, Haddison EC, Wang C, Johnson LF, Myer L, Davey DJ. Prevalence of curable STIs and bacterial vaginosis during pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. Sexually transmitted infections, 2022:98(7): 484-491. https://doi.org/10.1136/sextrans-2021-055057
13. Yeganeh N, Kreitchmann R, Leng M, Nielsen-Saines K, Gorbach PM, Klausner J. High Prevalence of Sexually Transmitted Infections in Pregnant Women Living in Southern Brazil. Sexually transmitted diseases. 2021; 48(2): 128-133. https://doi.org/10.1097/OLQ.0000000000001276
14. Cabeza J, García PJ, Segura E, García P, Escudero F, La Rosa S, et al. Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals. Sex Transm Infect . 2015 Feb; 91(1): 7-10. https://doi.org/10.1136/sextrans-2014-051531 PMID: 25107711.
15. Kiguen AX, Marramá M, Ruiz S, Estofan P, Venezuela RF, Mosmann JP, et al. Prevalence, risk factors and molecular characterization of Chlamydia trachomatis in pregnant women from Córdoba, Argentina: A prospective study. PLoS One. 2019 May 31;14(5): e0217245. 10.1371/journal.pone.0217245. PMID: 31150440; PMCID: PMC6544222.
16. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports, 2021; 70(4): 1-187. https://doi.org/10.15585/mmwr.rr7004a1
17. Rodrigues R, Sousa C, Vale N. Chlamydia trachomatis as a Current Health Problem: Challenges and Opportunities. Diagnostics (Basel, Switzerland), 2022: 12(8): 1795. https://doi.org/10.3390/diagnostics12081795
18. Mahony JB, Luinstra KE, Sellors JW, Jang D, Chernesky MA. Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men. Journal of clinical microbiology, 1992; 30(9): 2241-2245. https://doi.org/10.1128/jcm.30.9.2241-2245.1992
19. Davey JDL, Shull HI, Billings JD, Wang D, Adachi K, Klausner JD. Prevalence of Curable Sexually Transmitted Infections in Pregnant Women in Low-and Middle-Income Countries From 2010 to 2015: A Systematic Review. Sex Transm Dis . 2016 Jul; 43(7): 450-8 https://doi.org/10.1097/OLQ0000000000000460 PMID: 27322048
20. Vidwan NK, Regi A., Steinhoff M., Huppert JS, Staat MA, Dodd C, et al. Low Prevalence of Chlamydia trachomatis Infection in Non-Urban Pregnant Women in Vellore, S. India. 2012. PLoS ONE; 7(5): e34794. https://doi.org/10.1371/journal.pone.0034794 PMID: 22567090.
21. Labbe FR, Salazar MM, Vargas F. Prevalencia de infección por Chlamydia trachomatis y relación con el perfil de conductas sexuales en población adolescente de la Provincia de Osorno, Chile. Revista Chilena de Infectología, 2023: 40(1).
22. Marramá M. Prevalencia De Chlamydia Trachomatis En Embarazadas Asistidas En Centros De Salud Municipales De La Ciudad de Córdoba. 2016.
23. Black CM. Current Methods of Laboratory Diagnosis of Chlamydia trachomatis Infections. Clin Microbiol Reviews 1997; 10: 160-84.
24. Echániz-Avilés G, Calderón-Jaimes E, Carnalla-Barajas N, Soto Noguerón A, Cruz-Valdez A, Gatica-Marquina R. Prevalence of cervicovaginal infections caused by Chlamydia trachomatis among population of the City of Cuernavaca, Morelos. Salud Publica Mex 1992;34: 301-307.
25. Gupta K, Harrison SA, Davis NA, Culp ML, Hand SC, Simpson T. Prevalence of Chlamydia trachomatis Infection in Young Women and Associated Predictors. Sexually transmitted diseases, 2021; 48(8): 529-535. https://doi.org/10.1097/OLQ.0000000000001372
26. Zucotti A, Bolaño L, Berruezo FA, Vitozzi S, Bottiglieri M. Prevalencia de Chlamydia trachomatis en embarazadas durante el primer trimestre en una institución privada de la ciudad de Córdoba. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2 de septiembre de 2018 [citado 4 de junio de 2024]; 75(3): 183-8. Disponible en: Disponible en: https://revistas.unc.edu.ar/index.php/med/article/view/19810
27. Gutiérrez-Campos R, Gutiérrez-Santillán EA, Bravo-Aguirre DE, et al. Asociación entre aborto temprano e infección por Chlamydia trachomatis en Aguas Calientes, México. Rev Med Inst Mex Seguro Soc. 2020; 58(1): 21-27.
28. Wilkowska-Trojniel M, Zdrodowska-Stefanow B, Ostaszewska-Puchalska I, Redźko S, Przepieść J, et al. The influence of Chlamydia trachomatis infection on spontaneous abortion. Adv Med Sci. 2009; 54(1): 86-90.
29. Fischer N, Peeters I, Klamer S, Montourcy M, Cuylaerts V, Van Beckhoven D, et al. Prevalence estimates of genital Chlamydia trachomatis infection in Belgium: results from two cross-sectional studies. BMC infectious diseases. 2021; 21(1): 947. https://doi.org/10.1186/s12879-021-06646-y
30. Jorda G. Análisis de la utilidad del balance del contenido vaginal BACOVA, asociado a la infección por agentes bacterianos y virales prevalentes del tracto genital inferior en las mujeres de edad fértil. Tesis para acceder al título de Doctor 2016. UBA.
